United States · FDA National Drug Code directory
Vimpat
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0131-2477_51a12988-3e4b-c52b-e063-6394a90a7415
- Product NDC
- 0131-2477
- Form
- TABLET, FILM COATED
- Composition / generic term
- lacosamide
- Labeler
- UCB, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20090526
- Source listing expiry
- 20271231
Source-listed ingredients
- LACOSAMIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0131-2477-35) · 0131-2477-35
- 6 BLISTER PACK in 1 CARTON (0131-2477-60) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 0131-2477-60
- 1 BLISTER PACK in 1 CARTON (0131-2477-99) / 14 TABLET, FILM COATED in 1 BLISTER PACK · 0131-2477-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →